Patent details

EN | LT

LT - GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN TREATMENT OR PROPHYLAXIS OF TYPE I DIABETES

EN - GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN TREATMENT OR PROPHYLAXIS OF TYPE I DIABETES

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A01N 57/00
		A61K 31/66
		A01N 37/00
		A61K 31/19
		A61K 31/197
		A61K 31/4465
		A61K 38/20
		A61K 39/00
		A61K 39/39
		A61K 45/06
		A61P 3/08
		A61P 3/10

European patent
(11)	Number of the document	2621282
(13)	Kind of document	T
(96)	European patent application number	11833060.4
	Date of filing the European patent application	2011-09-28
(97)	Date of publication of the European application	2013-08-07
(45)	Date of publication and mention of the grant of the patent	2020-04-15
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2011/053732
	Date	2011-09-28

PCT application publication
(87)	Number	WO 2012/050907
	Date	2012-04-19

Priority applications
(30)	Number	Date	Country code
	201161433089 P	2011-01-14	US
	387398 P	2010-09-28	US

Inventors
(72)	KAUFMAN, Daniel, US TIAN, Jide, US

Grantee
(73)	The Regents of the University of California, 1111 Franklin Street, 12th Floor, Oakland, CA 94607, US

Title
(54)	GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN TREATMENT OR PROPHYLAXIS OF TYPE I DIABETES
	GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN TREATMENT OR PROPHYLAXIS OF TYPE I DIABETES